← FDA DRUG APPROVALS

FDA NDA · NDA018459

LEUCOVORIN CALCIUM

Sponsor: XANODYNE PHARM

APPLICATION
NDA018459
TYPE
NDA
ORIGINAL APPROVAL
1980-02-08
LATEST ACTION
2001-10-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

LEUCOVORIN CALCIUMDiscontinued
LEUCOVORIN CALCIUM EQ 5MG BASE · TABLET · ORAL

Approval history

2001-10-09Manufacturing (CMC) · Supplement 16AP
1997-11-25Manufacturing (CMC) · Supplement 14AP
1996-06-24Labeling · Supplement 12AP
1991-11-21Labeling · Supplement 11AP
1989-07-26Labeling · Supplement 8AP
1988-11-05Manufacturing (CMC) · Supplement 1AP
1988-11-04Manufacturing (CMC) · Supplement 3AP
1988-11-04Labeling · Supplement 2AP
1987-03-30Labeling · Supplement 6AP
1987-03-05Manufacturing (CMC) · Supplement 5AP
1980-02-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →